Parallel Bio
Using the immune system to cure disease
About Parallel Bio
Using the immune system to cure disease
Open positions (9)
Head of Platform Bioengineering & Assay Development
Senior Bioengineer, Vienna
Research Associate, Vienna
IT Operations Lead
Scientist (Immunology), Vienna
IT/OT Specialist
Corporate Program Manager, Firmwide
Head of Platform Bioengineering & Assay Development
Head of Biology
Company details
Funding
Total raised
$30M
Last stage
Series A
Investors
Founders
Robert
One of the world's leading experts in replacing animal models with human-first platforms.
Juliana Hilliard
Juliana is a co-founder and the CSO of Parallel Bio. She previously worked at System1 Biosciences managing R&D brain organoid drug discovery teams and has extensive experience developing mini-organ systems to better model human disease and discover new drugs.
LinkedIn
Robert DiFazio
Robert is a co-founder and CEO of Parallel Bio. Previously he was Director of Strategy & Research Development at Stanford University where he oversaw a $100M scientific portfolio and ran 8 large-scale R&D programs. He also worked in global health and ran vaccine programs with GSK, the NIH, and the Danish government. He completed his postdoctoral training at Stanford, holds a PhD from the University of Pittsburgh, and a BS from the University of Illinois.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.